Nephrocare Health Services Complete Financial Statements
In FY2026, Nephrocare Health Services (NEPHROPLUS) reported revenue ₹277 Cr, net profit ₹30 Cr and EPS ₹3.03, with a net profit margin of 10.8% and ROE of 2.7%. Full financial statements from FY2021 to FY2026 (6 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see Nephrocare Health Services screener.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
NEPHROPLUS Revenue, Net Profit & EBITDA — Year-on-Year Growth
NEPHROPLUS YoY (Mar 2025 vs Mar 2026) — revenue +24.2%, net profit +20.0%, EBITDA +12.7%, expenses +28.0%. Analyse Nephrocare Health Services shareholding analysis to track promoter, FII and institutional holdings.
NEPHROPLUS Income Statement — Revenue, EBITDA & Net Profit
Nephrocare Health Services revenue ₹277 Cr, EBITDA ₹62 Cr, net profit ₹30 Cr, EPS ₹3.03 (2026) — net profit margin 10.8%. Examine Nephrocare Health Services quarterly financials for recent quarterly revenue, profit and EPS trends.
| Particulars | Mar 2026 | Sept 2025 | Mar 2025 | Jun 2025 | Dec 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Revenue | 277 | 250 | 223 | 234 | 263 | 203 |
| Expenses | 215 | 182 | 168 | 180 | 199 | 153 |
| EBITDA | 62 | 68 | 55 | 54 | 64 | 50 |
| Operating Profit Margin % | 19.00% | 26.00% | 23.00% | 21.00% | 23.00% | 22.00% |
| Depreciation | 26 | 23 | 19 | 20 | 22 | 18 |
| Interest | 3 | 45 | 6 | 6 | 6 | 5 |
| Profit Before Tax | 33 | -1 | 30 | 29 | 36 | 26 |
| Tax | 3 | 9 | 5 | 5 | 4 | 6 |
| Net Profit | 30 | -10 | 25 | 24 | 32 | 20 |
| Earnings Per Share (₹) | 3.03 | -1.12 | 3.05 | 13.10 | 3.43 | 2.47 |
NEPHROPLUS Balance Sheet — Assets, Liabilities & Shareholders' Equity
NEPHROPLUS total assets ₹1,471 Cr, total equity ₹1,117 Cr, total liabilities ₹ Cr (2026) — ROE 2.7%.
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Total Assets | 1,471 | 997 | 806 | 666 | 571 | 428 |
| Current Assets | 839 | 545 | 390 | 324 | 285 | 178 |
| Fixed Assets | 436 | 396 | 356 | 239 | 205 | 192 |
| Capital Work in Progress | 6 | 6 | 1 | 34 | 43 | 2 |
| Investments | 33 | 51 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 544 | 450 | 393 | 322 | 234 |
| LIABILITIES | ||||||
| Total Liabilities | ||||||
| Current Liabilities | 55 | 129 | 150 | 103 | 81 | 75 |
| Non-Current Liabilities | ||||||
| SHAREHOLDERS' EQUITY | ||||||
| Total Equity | 1,117 | 584 | 414 | 389 | 396 | 259 |
| Share Capital | 20 | 2 | 2 | 5 | 5 | 4 |
| Reserves & Surplus | 1,096 | 579 | 409 | 384 | 387 | 245 |
NEPHROPLUS Cash Flow Statement — Operating, Investing & Financing
Nephrocare Health Services operating cash flow ₹135 Cr, investing ₹-125 Cr, financing ₹54 Cr, net cash flow ₹65 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 |
|---|---|---|---|---|---|
| Operating Activities | 135 | 72 | 11 | 14 | 32 |
| Investing Activities | -125 | -52 | -76 | -130 | -62 |
| Financing Activities | 54 | 27 | 60 | 121 | 36 |
| Net Cash Flow | 65 | 47 | -5 | 6 | 5 |